Allumia Ventures | Activity

Exit

Portfolio company Livara Health was acquired by Switchboard Health.

Livara Health

Switchboard Health Livara Health Allumia Ventures

mobihealthnews.comAUG 26, 2026

AUG 26, 2026

Investment

Participated in Switchboard Health's oversubscribed raise of more than $5M after Switchboard acquired portfolio company Livara Health.

Switchboard Health

Switchboard Health Livara Health Allumia Ventures

mobihealthnews.comAUG 26, 2026

AUG 26, 2026

Investment

Led Greater Good Health's $20.5M Series B (part of a $33M Series B and venture debt raise) to scale nurse-practitioner-led primary care for older adults.

Greater Good Health

Greater Good Health Allumia Ventures

greatergoodhealth.comMAR 5, 2026 finsmes.com

MAR 5, 2026

Investment

Led Affect Therapeutics' $26M Series B for its virtual mental health and substance use disorder care platform.

Affect Therapeutics

Affect Therapeutics Allumia Ventures

bhbusiness.comNOV 5, 2025 lifearcventures.com

NOV 5, 2025

Team Change

Formed its first advisory board with senior healthcare executives from Blue Shield of California, Providence, Froedtert Health, and Best Buy Health.

Allumia Ventures forms inaugural advisory board

Allumia Ventures

allumiaventures.comOCT 20, 2025

OCT 20, 2025

Exit

Qualtrics announced a $6.75B investment to acquire Press Ganey's Forsta business.

Press Ganey

Press Ganey Allumia Ventures

qualtrics.comOCT 6, 2025

OCT 6, 2025

Exit

Portfolio company Kyruus was acquired by RevSpring.

Kyruus

Kyruus Allumia Ventures

prnewswire.comSEP 23, 2025

SEP 23, 2025

Exit

Portfolio company Intelligent Retinal Imaging Systems (IRIS) was acquired by Topcon Healthcare.

IRIS (Intelligent Retinal Imaging Systems)

IRIS (Intelligent Retinal Imaging Systems)Allumia Ventures

topconhealthcare.comJUL 30, 2025

JUL 30, 2025

Exit

Portfolio company Xealth agreed to be acquired by Samsung to expand its digital health integration platform; the deal closed in October 2025.

Xealth

Xealth Allumia Ventures

geekwire.comJUL 8, 2025 geekwire.com

JUL 8, 2025

Milestone

Portfolio company Omada Health priced its IPO at $19 per share.

Omada Health

Omada Health Allumia Ventures

fiercehealthcare.comJUN 6, 2025

JUN 6, 2025

Exit

Portfolio company Protenus was acquired by Bluesight, expanding its diversion compliance capabilities.

Protenus

Protenus Allumia Ventures

bluesight.comJAN 9, 2025

JAN 9, 2025

News

Providence announced that Providence Ventures spun out to become the independent firm Allumia Ventures.

Providence Ventures spins out, forms Allumia Ventures

Allumia Ventures

blog.providence.orgJAN 7, 2025

JAN 7, 2025

New Fund

Spun out of Providence as independent firm Allumia Ventures, anchored by a $150M, 10-year commitment from Providence as the start of Fund III.

Fund III (spinout from Providence)

Allumia Ventures

geekwire.comJAN 7, 2025

JAN 7, 2025

Podcast

Partner Branden Fini discussed lessons learned as a healthtech VC.

Branden Fini on 'Pitfalls And Progress: Lessons From HealthTech VC'

Allumia Ventures

youtube.comAUG 9, 2024

AUG 9, 2024

Allumia Ventures Activity

Portfolio company Livara Health was acquired by Switchboard Health.

Participated in Switchboard Health's oversubscribed raise of more than $5M after Switchboard acquired portfolio company Livara Health.

Led Greater Good Health's $20.5M Series B (part of a $33M Series B and venture debt raise) to scale nurse-practitioner-led primary care for older adults.

Led Affect Therapeutics' $26M Series B for its virtual mental health and substance use disorder care platform.

Formed its first advisory board with senior healthcare executives from Blue Shield of California, Providence, Froedtert Health, and Best Buy Health.

Qualtrics announced a $6.75B investment to acquire Press Ganey's Forsta business.

Portfolio company Kyruus was acquired by RevSpring.

Portfolio company Intelligent Retinal Imaging Systems (IRIS) was acquired by Topcon Healthcare.

Portfolio company Xealth agreed to be acquired by Samsung to expand its digital health integration platform; the deal closed in October 2025.

Portfolio company Omada Health priced its IPO at $19 per share.

Portfolio company Protenus was acquired by Bluesight, expanding its diversion compliance capabilities.

Providence announced that Providence Ventures spun out to become the independent firm Allumia Ventures.

Spun out of Providence as independent firm Allumia Ventures, anchored by a $150M, 10-year commitment from Providence as the start of Fund III.

Partner Branden Fini discussed lessons learned as a healthtech VC.